1.Purification, crystallographic analysis of rhesus MHC-I Mamu-A*02 complexed with simian immunodeficiency virus nonapeptide.
Lianpan DAI ; Bin ZHOU ; Jianxun QI ; Ying MA ; George F GAO ; Xicai YANG
Chinese Journal of Biotechnology 2009;25(7):1028-1034
Rhesus macaque (Macaca mulatta) is the best model to study of human immunodeficiency virus (HIV) infection and to develop acquired immunodeficiency syndrome (AIDS) vaccine. The crystal structure of its major histocompatibility antigen complex (MHC) is helpful to understand the mechanism of HIV immune evasion. In this study, we cloned the light chain (beta2m) of MHC class I allele of rhesus macaques, Mamu-A*02, and inserted it into pET21a(+) vector. We transfected the recombinant plasmid pET21a(+)-Mamu-beta2m and pET21a(+)-Mamu-alpha into BL21(DE3). Mamu-A*02 and beta2m were expressed in the form of inclusion bodies in BL21 (DE3). We co-refolded the inclusion bodies of Mamu-alpha and Mamu-beta2m with SIV nonapeptide YY9 and obtained the correct refolded protein complex. Then we purified the protein complex by the gel filtration and anion-exchange column. With hanging-drop method, we screened and optimized for the protein crystal. We managed to collect a X-ray diffraction with the resolution to 2.8 angstroms in the condition of 0.1 mol/L BIS-TRIS (pH5.5), 2.0 mol/L(NH4)2SO4. This crystal belong to perpendicular space group P2(1)2(1)2(1), with unit-cell parameters a = 128.99 angstroms, b = 129.01 angstroms, c = 129.03 angstroms. This data is available for the structure determination.
Animals
;
Crystallography, X-Ray
;
Epitopes
;
immunology
;
Escherichia coli
;
genetics
;
metabolism
;
Histocompatibility Antigens Class I
;
biosynthesis
;
genetics
;
Macaca mulatta
;
Oligopeptides
;
biosynthesis
;
genetics
;
Simian Immunodeficiency Virus
;
immunology
2.Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic.
William J LIU ; Haixia XIAO ; Lianpan DAI ; Di LIU ; Jianjun CHEN ; Xiaopeng QI ; Yuhai BI ; Yi SHI ; George F GAO ; Yingxia LIU
Frontiers of Medicine 2021;15(4):507-527
The avian influenza A (H7N9) virus is a zoonotic virus that is closely associated with live poultry markets. It has caused infections in humans in China since 2013. Five waves of the H7N9 influenza epidemic occurred in China between March 2013 and September 2017. H7N9 with low-pathogenicity dominated in the first four waves, whereas highly pathogenic H7N9 influenza emerged in poultry and spread to humans during the fifth wave, causing wide concern. Specialists and officials from China and other countries responded quickly, controlled the epidemic well thus far, and characterized the virus by using new technologies and surveillance tools that were made possible by their preparedness efforts. Here, we review the characteristics of the H7N9 viruses that were identified while controlling the spread of the disease. It was summarized and discussed from the perspectives of molecular epidemiology, clinical features, virulence and pathogenesis, receptor binding, T-cell responses, monoclonal antibody development, vaccine development, and disease burden. These data provide tools for minimizing the future threat of H7N9 and other emerging and re-emerging viruses, such as SARS-CoV-2.
Animals
;
COVID-19
;
China/epidemiology*
;
Humans
;
Influenza A Virus, H7N9 Subtype
;
Influenza in Birds/epidemiology*
;
Influenza, Human/prevention & control*
;
Poultry
;
SARS-CoV-2